AI assistant
Sending…
MIMEDX GROUP, INC. — Director's Dealing 2022
Apr 12, 2022
32206_dirs_2022-04-12_0614f24e-88bf-422e-b98e-fe43bade786c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MIMEDX GROUP, INC. (MDXG)
CIK: 0001376339
Period of Report: 2022-04-08
Reporting Person: Graves Mark (SVP & Chief Compliance Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-04-08 | Common Stock | A | 48485 | $4.62 | Acquired | 137499 | Direct |
Footnotes
F1: Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years. Grant is exempt under Rule 16b-3.
More from MIMEDX GROUP, INC.
Annual Report
2026
Apr 29
Regulatory Filings
2026
Apr 16
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Regulatory Filings
2026
Feb 25
Annual Report
2026
Feb 25
Director's Dealing
2026
Feb 19
Major Shareholding Notification
2026
Feb 13
Regulatory Filings
2026
Jan 12
Director's Dealing
2025
Nov 10